Cargando…
Expression of eosinophils, RANTES and IL-25 in the first phase of Hymenoptera venom immunotherapy
INTRODUCTION: Venom immunotherapy (VIT) can protect against severe anaphylactic reactions (SR) in 80–100% of subjects allergic to Hymenoptera venom. The mechanisms of induction of immunological tolerance produced by VIT are still little known. It has been shown that VIT modulates Treg activity, Th2...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507153/ https://www.ncbi.nlm.nih.gov/pubmed/32994784 http://dx.doi.org/10.5114/ada.2019.83655 |